ArticleOncology letters2018

MicroRNA-137-regulated AKT serine/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non-small cell lung cancer.

Zhuming Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.